Etilamfetamine

Ethylamphetamine
INN: Etilamfetamine
Clinical data
Trade names	Apetinil; Adiparthrol
Other names	Etilamfetamine; Ethylamphetamine; N-Ethylamphetamine; PAL-99; PAL99
Routes of; administration	Oral, sublingual, insufflated, inhaled (vaporized), intravenous, rectal
ATC code	A08AA06 (WHO) ;
Legal status
Legal status	BR: Class B1 (Psychoactive drugs); CA: Schedule I; DE: Anlage II (Authorized trade only, not prescriptible); UK: Class C; US: Schedule I;
Pharmacokinetic data
Metabolism	Hepatic (N-dealkylation, others)
Metabolites	Amphetamine
Excretion	Urine (5–18% as amphetamine)
Identifiers
	IUPAC name N-Ethyl-1-phenyl-propan-2-amine;
CAS Number	457-87-4 ;
PubChem CID	9982;
ChemSpider	9588 ;
UNII	022YON1XMX;
KEGG	D07114 ;
ChEMBL	ChEMBL276443 ;
CompTox Dashboard (EPA)	DTXSID10860359 ;
ECHA InfoCard	100.230.711
Chemical and physical data
Formula	C11H17N
Molar mass	163.264 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N(C(Cc1ccccc1)C)CC;
	InChI InChI=1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3 ; Key:YAGBSNMZQKEFCO-UHFFFAOYSA-N ;
	(verify)

Etilamfetamine, also known as N-ethylamphetamine and formerly sold under the brand names Apetinil and Adiparthrol, is a stimulant drug of the amphetamine family. It was invented in the early 20th century and was subsequently used as an anorectic or appetite suppressant in the 1950s, but was not as commonly used as other amphetamines such as amphetamine, methamphetamine, and benzphetamine, and was largely discontinued once newer drugs such as phenmetrazine were introduced.